table of content
1 Introduction to Research & Analysis Reports
1.1 Artificial Intelligence Drug Development Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Artificial Intelligence Drug Development Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Intelligence Drug Development Overall Market Size
2.1 Global Artificial Intelligence Drug Development Market Size: 2021 VS 2028
2.2 Global Artificial Intelligence Drug Development Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Artificial Intelligence Drug Development Players in Global Market
3.2 Top Global Artificial Intelligence Drug Development Companies Ranked by Revenue
3.3 Global Artificial Intelligence Drug Development Revenue by Companies
3.4 Top 3 and Top 5 Artificial Intelligence Drug Development Companies in Global Market, by Revenue in 2021
3.5 Global Companies Artificial Intelligence Drug Development Product Type
3.6 Tier 1, Tier 2 and Tier 3 Artificial Intelligence Drug Development Players in Global Market
3.6.1 List of Global Tier 1 Artificial Intelligence Drug Development Companies
3.6.2 List of Global Tier 2 and Tier 3 Artificial Intelligence Drug Development Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Artificial Intelligence Drug Development Market Size Markets, 2021 & 2028
4.1.2 Drug Design
4.1.3 Drug Synthesis
4.1.4 Other
4.2 By Type - Global Artificial Intelligence Drug Development Revenue & Forecasts
4.2.1 By Type - Global Artificial Intelligence Drug Development Revenue, 2017-2022
4.2.2 By Type - Global Artificial Intelligence Drug Development Revenue, 2023-2028
4.2.3 By Type - Global Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Artificial Intelligence Drug Development Market Size, 2021 & 2028
5.1.2 Tumor
5.1.3 Nervous System
5.1.4 Other
5.2 By Application - Global Artificial Intelligence Drug Development Revenue & Forecasts
5.2.1 By Application - Global Artificial Intelligence Drug Development Revenue, 2017-2022
5.2.2 By Application - Global Artificial Intelligence Drug Development Revenue, 2023-2028
5.2.3 By Application - Global Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Artificial Intelligence Drug Development Market Size, 2021 & 2028
6.2 By Region - Global Artificial Intelligence Drug Development Revenue & Forecasts
6.2.1 By Region - Global Artificial Intelligence Drug Development Revenue, 2017-2022
6.2.2 By Region - Global Artificial Intelligence Drug Development Revenue, 2023-2028
6.2.3 By Region - Global Artificial Intelligence Drug Development Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Artificial Intelligence Drug Development Revenue, 2017-2028
6.3.2 US Artificial Intelligence Drug Development Market Size, 2017-2028
6.3.3 Canada Artificial Intelligence Drug Development Market Size, 2017-2028
6.3.4 Mexico Artificial Intelligence Drug Development Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Artificial Intelligence Drug Development Revenue, 2017-2028
6.4.2 Germany Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.3 France Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.4 U.K. Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.5 Italy Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.6 Russia Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.7 Nordic Countries Artificial Intelligence Drug Development Market Size, 2017-2028
6.4.8 Benelux Artificial Intelligence Drug Development Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Artificial Intelligence Drug Development Revenue, 2017-2028
6.5.2 China Artificial Intelligence Drug Development Market Size, 2017-2028
6.5.3 Japan Artificial Intelligence Drug Development Market Size, 2017-2028
6.5.4 South Korea Artificial Intelligence Drug Development Market Size, 2017-2028
6.5.5 Southeast Asia Artificial Intelligence Drug Development Market Size, 2017-2028
6.5.6 India Artificial Intelligence Drug Development Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Artificial Intelligence Drug Development Revenue, 2017-2028
6.6.2 Brazil Artificial Intelligence Drug Development Market Size, 2017-2028
6.6.3 Argentina Artificial Intelligence Drug Development Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Artificial Intelligence Drug Development Revenue, 2017-2028
6.7.2 Turkey Artificial Intelligence Drug Development Market Size, 2017-2028
6.7.3 Israel Artificial Intelligence Drug Development Market Size, 2017-2028
6.7.4 Saudi Arabia Artificial Intelligence Drug Development Market Size, 2017-2028
6.7.5 UAE Artificial Intelligence Drug Development Market Size, 2017-2028
7 Players Profiles
7.1 Insilico Medicine
7.1.1 Insilico Medicine Corporate Summary
7.1.2 Insilico Medicine Business Overview
7.1.3 Insilico Medicine Artificial Intelligence Drug Development Major Product Offerings
7.1.4 Insilico Medicine Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.1.5 Insilico Medicine Key News
7.2 Cyclica
7.2.1 Cyclica Corporate Summary
7.2.2 Cyclica Business Overview
7.2.3 Cyclica Artificial Intelligence Drug Development Major Product Offerings
7.2.4 Cyclica Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.2.5 Cyclica Key News
7.3 XtalPi Inc.
7.3.1 XtalPi Inc. Corporate Summary
7.3.2 XtalPi Inc. Business Overview
7.3.3 XtalPi Inc. Artificial Intelligence Drug Development Major Product Offerings
7.3.4 XtalPi Inc. Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.3.5 XtalPi Inc. Key News
7.4 Exscientia Limited
7.4.1 Exscientia Limited Corporate Summary
7.4.2 Exscientia Limited Business Overview
7.4.3 Exscientia Limited Artificial Intelligence Drug Development Major Product Offerings
7.4.4 Exscientia Limited Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.4.5 Exscientia Limited Key News
7.5 AiCure, LLC
7.5.1 AiCure, LLC Corporate Summary
7.5.2 AiCure, LLC Business Overview
7.5.3 AiCure, LLC Artificial Intelligence Drug Development Major Product Offerings
7.5.4 AiCure, LLC Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.5.5 AiCure, LLC Key News
7.6 Atomwise
7.6.1 Atomwise Corporate Summary
7.6.2 Atomwise Business Overview
7.6.3 Atomwise Artificial Intelligence Drug Development Major Product Offerings
7.6.4 Atomwise Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.6.5 Atomwise Key News
7.7 Biovista Inc.
7.7.1 Biovista Inc. Corporate Summary
7.7.2 Biovista Inc. Business Overview
7.7.3 Biovista Inc. Artificial Intelligence Drug Development Major Product Offerings
7.7.4 Biovista Inc. Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.7.5 Biovista Inc. Key News
7.8 Breg?Inc.
7.8.1 Breg?Inc. Corporate Summary
7.8.2 Breg?Inc. Business Overview
7.8.3 Breg?Inc. Artificial Intelligence Drug Development Major Product Offerings
7.8.4 Breg?Inc. Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.8.5 Breg?Inc. Key News
7.9 Numerate
7.9.1 Numerate Corporate Summary
7.9.2 Numerate Business Overview
7.9.3 Numerate Artificial Intelligence Drug Development Major Product Offerings
7.9.4 Numerate Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.9.5 Numerate Key News
7.10 Cloud Pharmaceuticals
7.10.1 Cloud Pharmaceuticals Corporate Summary
7.10.2 Cloud Pharmaceuticals Business Overview
7.10.3 Cloud Pharmaceuticals Artificial Intelligence Drug Development Major Product Offerings
7.10.4 Cloud Pharmaceuticals Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.10.5 Cloud Pharmaceuticals Key News
7.11 IBM
7.11.1 IBM Corporate Summary
7.11.2 IBM Business Overview
7.11.3 IBM Artificial Intelligence Drug Development Major Product Offerings
7.11.4 IBM Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.11.5 IBM Key News
7.12 NuMedii
7.12.1 NuMedii Corporate Summary
7.12.2 NuMedii Business Overview
7.12.3 NuMedii Artificial Intelligence Drug Development Major Product Offerings
7.12.4 NuMedii Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.12.5 NuMedii Key News
7.13 BenevolentAI
7.13.1 BenevolentAI Corporate Summary
7.13.2 BenevolentAI Business Overview
7.13.3 BenevolentAI Artificial Intelligence Drug Development Major Product Offerings
7.13.4 BenevolentAI Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.13.5 BenevolentAI Key News
7.14 Lam Therapeutics
7.14.1 Lam Therapeutics Corporate Summary
7.14.2 Lam Therapeutics Business Overview
7.14.3 Lam Therapeutics Artificial Intelligence Drug Development Major Product Offerings
7.14.4 Lam Therapeutics Artificial Intelligence Drug Development Revenue in Global Market (2017-2022)
7.14.5 Lam Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
